Drug Shortage Report for GLYCOPYRROLATE INJECTION USP

Last updated on 2023-04-17 History
Report ID 181847
Drug Identification Number 02473895
Brand name GLYCOPYRROLATE INJECTION USP
Common or Proper name GLYCOPYRROLATE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) GLYCOPYRROLATE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size 10 X 2 ML VIALS
ATC code A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-01-20
Estimated end date 2023-04-14
Actual end date 2023-04-14
Shortage status Resolved
Updated date 2023-04-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-04-17 French Compare
v7 2023-04-17 English Compare
v6 2023-03-29 French Compare
v5 2023-03-29 English Compare
v4 2023-03-29 English Compare
v3 2023-01-21 English Compare
v2 2023-01-19 French Compare
v1 2023-01-19 English Compare

Showing 1 to 8 of 8